The differential expression of HSPA5 and HSPA6 between CTCL and normal CD4+ T cells highlights an important role of ER stress signaling and the UPR in malignant T-cell biology and identifies these proteins as potential therapeutic targets for CTCL. The gene discussed is HSPA6; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.